-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-roadmap-interventions.pdf
November 01, 2020 - Informative Statements To Communicate Results of Systematic Reviews From
GRADE
Appendix C. … The GRADE Working Group developed in 2004 an approach for rating the certainty in
evidence that has … Recently, the GRADE Working Group has proposed an approach for making narrative
statements. … Using EPOC and GRADE suggestions, we
developed a framework (Figure 1) for key overlapping constructs … Informative Statements To Communicate Results of Systematic Reviews From GRADE
Appendix C.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/integrating-evidence_methods.pdf
February 01, 2015 - assessment of bodies of evidence again using their own
criteria and judgment, while others do not grade … Assessments that are compatible include the EPC SOE, GRADE,
and USPTF tools.16-18 However, no matter … However, the process for
how to determine if there is sufficient evidence to change a prior grade is … What is enough, in terms of studies/type of evidence, to prompt a change in grade?
4. … What is enough, in terms of studies/type of evidence, to prompt a change in grade?
5.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-2005_executive.pdf
January 01, 2005 - followup was 8
months, and all three studies had significant bias
that may invalidate the results (Grade … These
analyses had minimal bias and their results are
considered valid (Grade A). … (Grade C) nonrandomized study. … This one study on Stretta™ versus sham had a
small number of patients and short duration of
followup (Grade … antireflux
medications compared to medical patients; less bodily pain; no
difference in esophagitis grade
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-executive-summary.pdf
August 01, 2024 - RT
alone, frequency: 1 vs.0 grade 4 events
(n=110); or 20 vs.0 overall events
(n=585). … cisplatin, with grade 3+ toxicity
frequency of 61% vs. 42% (p<0.001,
n=682) and 26% vs. 16% (p<0.001 … Low
Neutropenia
(grade 3 or 4)
1; RCT; n=144 No significant difference, imprecise
estimates. … Low
Note: Remaining comparisons not mentioned in the table received an insufficient grade. … All harms are grade 3 or 4 unless
specified otherwise.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-protocol.pdf
September 26, 2023 - Guyatt GH OA, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ; GRADE
Working Group. … GRADE guidelines: 11. … Reference 21: Guyatt GH OA,
Kunz R, Vist GE, Falck-Ytter Y,
Schünemann HJ; GRADE Working
Group. … GRADE
guidelines: 11. … r) adj2 (assess* or burden or grade or grading or invasive*
or metastas?
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-lung-cancer.pdf
August 01, 2021 - Regarding toxicity, over 750 Grade 3 or Grade 4 complications are listed in CTCAE v5 for
radiation therapy … Rather than model each complication, observations were
created for “CTCAE grade 3” and “CTCAE grade … This approach also allows the
definition to capture Grade 3 or Grade 4 complications, regardless of … infarction
Unexpected return to operating room (any cause)
Radiation therapy complications
CTCAE grade … 3 or 4 complications due to radiotherapy
Systemic therapy complications
CTCAE grade 3 or 4 complications
-
effectivehealthcare.ahrq.gov/products/grades-predictive-values/abstract
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/meditation_research-protocol.pdf
October 17, 2012 - research is very unlikely
to change our confidence in the estimate of the effect); (2) “moderate” grade … We will classify evidence pertaining to
Key Questions into four basic
categories: (1) “high” grade … research is very unlikely to change our
confidence in the estimate of the
effect); (2) “moderate” grade … but
there are more direct measures of
those domains.
3) To specify the details of how
we will grade … Protocol Revised Protocol Rationale
and is likely to change the estimate);
and (4) “insufficient” grade
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-immunotherapy-2010_disposition-comments.pdf
January 01, 2010 - Our group did not use
statistical significance/precision to grade articles. … Instead, as
described in our methods section, In our grade assignments, we
considered the limitations … We used the GRADE tool, as
a recognized method when performing effectiveness reviews. … In our grade assignments, we considered the limitations of
each individual study’s quality (using the … We did not grade Pulmonary function test because it is an
intermediate outcome.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-prognostic-tests_research.pdf
August 22, 2012 - recurrence include com-
edo histology, younger age, larger tumor size, high pathologic or
nuclear grade … We analyzed how testing varied by patient age, tumor size, and tumor
grade—all factors known to increase … Grade: We defined grade using the data
fields provided by SEER: well differenti-
ated, moderately/intermediately … Women with DCIS also had a higher incidence of un-
known tumor size and grade (Table 1). … , women with DCIS
were more likely to have smaller tumors and higher grade
tumors.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lumbar-fusion-protocol.pdf
June 20, 2024 - I (0%−25%), Grade II (25%−50%), Grade III (50%−75%),
Grade IV (75%−100%) and Grade V (>100%). … Grades I and II are considered low-grade slip, are
most common, and are least likely to progress.3,4,11 … Grades III-V are considered a high-grade slip.
2
Management of Degenerative Lumbar Spine … DLS is controversial.6,12,20 Low-grade DLS is the most common6 and
may be an incidental radiographic … Management of symptomatic degenerative low-grade lumbar
spondylolisthesis.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research-protocol.pdf
September 01, 2016 - qualitative dis-
cordance (preliminarily defined as change in direction of conclusion and/or level of grade … We will conduct the following for each outcome by drug comparison:
• We will grade the level evidence
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
October 01, 2015 - These
include the stage of the cancer, tumor grade (higher grade
tumors are more likely to recur and … Does the comparative effectiveness differ according
to tumor characteristics, such as stage, grade, … • Effects of tumor grade: Across urinary biomarkers,
sensitivity increased with higher tumor grade … with higher tumor grade. … Stage,
grade, tumor
multiplicity,
primary vs.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_executive.pdf
December 01, 2014 - cancer in healthy men of all ages, concluding that the
harms of screening outweigh the benefits (Grade … Current practice is to use tumor
grade as the primary prognostic variable in patients with
clinically … by
Owens and colleagues.21 Briefly, a high grade reflects high
confidence that the effect estimate … lies close to the true
effect; a moderate grade reflects moderate confidence; a
6
low grade reflects … The
decision to grade an evidence base as insufficient rather
than low often reflected an imprecise
-
effectivehealthcare.ahrq.gov/sites/default/files/clinical-pathway-methods-report-appendix-k.pdf
February 01, 2018 - Grade of Recommendation: Weak recommendation based on low-quality
evidence, 2C. … Grade of Recommendation: Strong recommendation based on low-quality evidence, 1C. … ) system
Recommendation rating: GRADE system
2. … and ‘we suggest’ for a weak
recommendation grade.”
4. … rating: GRADE system
5.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/screening-counseling-interventions-protocol-amendment.pdf
February 05, 2025 - Depression and Suicide Risk (B and I
Grades)
− Screening for Eating Disorders (adolescents only; I
Grade … unhealthy Drug Use
(adolescent only; B and I Grades)
− Counseling regarding Illicit Drug Use (I Grade … the guidance established by
the Grading of Recommendations Assessment, Development and Evaluation
(GRADE … We
will grade the seven outcomes, rated as most important for decision making. … GRADE guidelines: 3. Rating
the quality of evidence.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability-quiz.ppt
May 29, 2025 - Assessing Applicability: Interactive Case Study Quiz
Assessing Applicability
Interactive Quiz
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Systematic Reviews Methods Guide
www.ahrq.gov
Assessing Applicability Interactive Quiz
Why might trials with run-in periods and …
-
effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability-quiz.ppt
May 29, 2025 - Assessing Applicability: Interactive Case Study Quiz
Assessing Applicability
Interactive Quiz
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Systematic Reviews Methods Guide
www.ahrq.gov
Assessing Applicability Interactive Quiz
Why might trials with run-in periods and …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/aggression_executive.pdf
October 01, 2016 - Mirroring our decision not to assess the
risk of bias of pre/post studies, we did not grade the SOE … We report
below only on findings from trials or studies for which we
could grade SOE. … in this report did not control for clustering in
their statistical analyses, which weakened the SOE grade … Their inherent
high risk of bias precludes drawing inferences of causality,
so we did not grade SOE … No KQs had comparative data supporting an SOE grade
that exceeded low strength of evidence.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_surveillance.pdf
August 01, 2012 - CRT
(2DRT)
Grade 3 dysphagia
57% vs. 58%
Time of onset of
grade 3 dysphagia
6.4 vs. 4.8 weeks … ; p
= 0.05
Duration grade 3
dysphagia toxicity
4.9 vs. 7.5 weeks; p
= 0.03 … CRT (n=14;
dose: NR)
2008- 2010
Or
Minimum
(12 months)
Grade 3 dysphagia IMRT vs. … Conventional
RT(2DRT)
Grade 3 dysphagia
57% vs. 58%
Time of onset of grade 3
dysphagia
6.4 … )
Dermatitis (RTOG Grade 3–4)
44 (45) vs. 92 (65); p=0.02
Mucositis (RTOG Grade 3–4)
73 (75%)